Shilpa Medicare arm to infuse USD 2 million in Alveolus Bio
Raichur: Shilpa Medicare has announced that Shilpa Pharma Inc, a wholly owned subsidiary of the company, will make a strategic investment of USD 2 million in Alveolus Bio, a biotech startup based out of USA, advancing inhaled live biotherapeutics and small molecule therapies for chronic and life‐threatening lung diseases.
The investment will be made in the form of SAFE (Simple Agreement for Future Equity) Notes, which will convert into a percentage of shareholding upon fulfilment of certain conditions.
Under this strategic engagement, Shilpa Biologics Private Limited – the biologics arm of Shilpa Medicare – will additionally serve asthe exclusive global development and manufacturing partner for Alveolus Bio.
This collaboration combines Shilpa’s expertise in turnkey biologics development, process optimization, and manufacturing with Alveolus Bio’s cutting‐edge resMIT platform, which engineers inhalable live therapeutics to address hard‐to‐ treat respiratory conditions like COPD, Bronchopulmonary Dysplasia, and Pulmonary Fibrosis.
“Shilpa Medicare has always been at the forefront of enabling breakthrough biologics with our world‐class development and manufacturing capabilities,” said Vishnukant Bhutada, Managing Director, Shilpa Medicare Limited. “This partnership with Alveolus Bio not only strengthens our innovation pipeline but also positions Shilpa as a key global partner for biotech companies looking to translate bold science into scalable clinical and commercial solutions.”
The investment will fund Alveolus Bio’s lead COPD program through Phase 2 clinical trials and accelerate additional preclinical programs. Importantly, the collaboration also creates a platform for co‐development and future manufacturing partnerships.
The SAFE notes investment is expected to be completed within a month of signing the definitive agreements.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.